Burns
Volume 31, Issue 7 , Pages 870-873 , November 2005

The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit

  • Zulal Ozkurt

      Affiliations

    • Department of Clinical Bacteriology and Infectious Diseases, School of Medicine, Ataturk University, Erzurum, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 4423166333/2025; fax: +90 4423166340.
    • ,
  • Mustafa Ertek

      Affiliations

    • Department of Clinical Bacteriology and Infectious Diseases, School of Medicine, Ataturk University, Erzurum, Turkey
    • ,
  • Serpil Erol

      Affiliations

    • Department of Clinical Bacteriology and Infectious Diseases, School of Medicine, Ataturk University, Erzurum, Turkey
    • ,
  • Ulku Altoparlak

      Affiliations

    • Department of Microbiology and Clinical Microbiology, School of Medicine, Ataturk University, Erzurum, Turkey
    • ,
  • M. Nuran Akcay

      Affiliations

    • Department of General Surgery, Burn Unit, School of Medicine, Ataturk University, Erzurum, Turkey

,Accepted 13 April 2005.

References 

  1. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247–50.
  2. Goosssens H. Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group. Clin Microbiol Infect. 2003;9:980–983
  3. Deshpande LM, Fritsche TR, Jones RN. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2004;49(4):231–236
  4. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis. 2002;34(3):340–345
  5. Troillet N, Samore MH, Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis. 1997;25(5):1094–1098
  6. Gulay Z, Atay T, Amyes SG. Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital. J Chemother. 2001;13(5):546–554
  7. Cao B, Whang H, Sun H, Zhu Y, Chen M. Risk factors and clinical outcomes of nosocomial multi-drug-resistant Pseudomonas aeruginosa infections. J Hosp Infect. 2004;57:112–118
  8. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect. 2005;59(2):96–101
  9. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31(8):481–98.
  10. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470–85.
  11. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003;53(1):6–13
  12. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001;27(2):136–139
  13. Geyik MF, Aldemir M, Hosoglu S, Tacyildiz HI. Epidemiology of burn unit infections in children. Am J Infect Control. 2003;31(6):342–346
  14. Pruitt BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg. 1998;22(2):135–145
  15. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004;30(4):357–361
  16. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns. 2004;30(7):660–664
  17. Oncul O, Yuksel F, Altunay H, Acikel C, Celikoz B, Cavuslu S. The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. Burns. 2002;28(8):738–744
  18. Zhang R, Jin Y, Han C. The isolation of Pseudomonas aeruginosa from burn wound and the analysis of its antibiotic resistant spectrum. Zhonghua Shao Shang Za Zhi. 2002;18(5):285–287[Abstract]
  19. Lund CL, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet. 1994;79:352
  20. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 6th ed. Approved Standard. NCCLS Document M2-A6, vol. 17, No. 1, Pennsylvania.
  21. Lagatolla C, Tonin EA, Monti-Bragadin C, Dolzani L, Gombac F, Bearzi C, et al. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital. Emerg Infect Dis. 2004;10(3):535–538
  22. Lynch MJ, Drusano GL, Mobley HL. Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1987;31(12):1892–1896
  23. Vurma-Rap U, Kayser FH, Hadorn K, Wiederkehr F. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy. Eur J Clin Microbiol Infect Dis. 1990;9(8):580–587
  24. Krcmery V, Trup J, Kunova A, Spanik S, Drgona L, Oravcova E, et al. Imipenem-resistant P. aeruginosa bacteremia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res. 1996;16(2-3):43–49
  25. Mokaddads EM, Sanyal SC. Resistance patterns of Pseudomonas aeruginosa to carbapenem and piperacillin/tazobactam. J Chemother. 1999;11(2):93–96
  26. Herruzo Cabrera R, Garcia Torres V, Martinez Ratero S, Denia Lafuente R, Rey Calero J. Risk factors for local infection in burns. Multivariate study. Med Clin (Barc) 1996;106(3):91–4 [Abstract].
  27. Wong TH, Tan BH, Ling ML, Song C. Multi-resistant Acinetobacter baumannii on a burns unit – clinical risk factors and prognosis. Burns. 2002;28(4):349–357
  28. Edmond MB, Wenzel RP. Isolation. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and practice of infectious diseases. 5th ed.. New York: Churchill Livingstone; 2000;p. 2991–3004

☆ This study will be presented as a poster in XV Congress of European Clinical Microbiology and Infectious Diseases, 2–5 April 2005, Copenhagen, Denmark.

PII: S0305-4179(05)00134-8

doi: 10.1016/j.burns.2005.04.015

Burns
Volume 31, Issue 7 , Pages 870-873 , November 2005

Article Tools